Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - clostridium novyi type b - toxoid - unknown - clostridium novyi type b - toxoid vaccine-toxoid active 0.0 - active constituent

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - clostridium novyi type b - toxoid - unknown - clostridium novyi type b - toxoid vaccine-toxoid active 0.0 - active constituent

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; corynebacterium pseudotuberculosis - toxoid; thiomersal - misc. vaccines or anti sera - clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p; corynebacterium pseudotuberculosis - toxoid vaccine-toxoid active 0.0 p; thiomersal mercury other 0.13 g/l - immunotherapy - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - black disease | blackleg | cheesy gland | enterotoxaemia (pulpy kidney) | malignant oedema | tetanus | clostridium perfringens type d | lymphadenitis | lymphangitis | tetanus vaccination

Nuova Zelanda - inglese - Ministry for Primary Industries

elanco new zealand - clostridium tetani toxoid; clostridium novyi type b toxoid/cells; clostridium septicum toxoid; clostridium perfringens type d toxoid; clostridium chauvoei toxoid/cells; hydroxocobalamin - clostridium tetani toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium septicum toxoid 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; hydroxocobalamin 1 g/litre - vaccine

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - selenium as sodium selenate; clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal - misc. vaccines or anti sera - selenium as sodium selenate mineral-selenium active 0.5 g/l; clostridium chauvoei - toxoid vaccine-toxoid active 0.0 ph.eur.; clostridium novyi type b - toxoid vaccine-toxoid active 3.5 units/ml; clostridium perfringens type d toxoid vaccine-toxoid active 5.0 units/ml; clostridium septicum - toxoid vaccine-toxoid active 2.5 units/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 units/ml; thiomersal mercury other 0.15 mg/ml - immunotherapy - cattle | goat | lamb | sheep | beef | billy | bos indicus | bos taurus | bovine | buck | buffalo | bull | bullock | calf | capra - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | selenium deficiency | tetanus | clostridium perfringens type d | tetanus vaccination | white muscle disease

Italia - inglese - HMA (Heads of Medicines Agencies)

ceva salud animal - clostridium chauvoei 90 %, clostridium novyi alpha toxoid 3.5 iu/ml, clostridium perfringens a 1.1 iu/ml, clostridium perfringens type c toxoid 10 iu/ml, clostridium perfringens type d toxoid 5 iu/ml, clostridium septicum 2.5 iu/ml, clostridium sordelli 100 %, clostridium tetani toxoid 2.5 iu/ml - suspension for injection - sheep food - clostridium vaccine

Stati Uniti - inglese - NLM (National Library of Medicine)

sanofi pasteur inc. - clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h), bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (unii: f4tn0ipy37) (bordetella pertussis toxoid antigen (glutaraldehyde inactivated) - unii:f4tn0ipy37 - clostridium tetani toxoid antigen (formaldehyde inactivated) 5 [lf] in 0.5 ml - adacel® is a vaccine indicated for: - active booster immunization against tetanus, diphtheria and pertussis. adacel is approved for use in individuals 10 through 64 years of age. immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age. a severe allergic reaction (e.g., anaphylaxis) after a previous dose of any tetanus toxoid, diphtheria toxoid or pertussis containing vaccine or any other component of this vaccine is a contraindication to administration of adacel. [see description (11). ] because of uncertainty as to which component of the vaccine may be responsible, none of the components should be administered. alternatively, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered. encephalopathy (e.g., coma, prolonged seizures, or decreased level of consciousness) within 7 days of a previous dose of a pertussis containing vaccine not attributable to another identifiable cause is a contraindicatio

Stati Uniti - inglese - NLM (National Library of Medicine)

sanofi pasteur inc. - clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h) - clostridium tetani toxoid antigen (formaldehyde inactivated) 5 [lf] in 0.5 ml - tenivac® is a vaccine indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older. a severe allergic reaction (e.g., anaphylaxis) after a previous dose of tenivac or any other tetanus toxoid or diphtheria toxoid-containing vaccine or any other component of this vaccine is a contraindication to administration of tenivac. [see description (11) .] because of uncertainty as to which component of the vaccine may be responsible, none of the components should be administered. alternatively, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. there are no adequate and well-controlled studies of tenivac administration in pregnant women in t

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pfizer animal health a div of pfizer australia pty ltd - clostridium chauvoei - toxoid | clostridium novyi type b - toxoid | clostridium perfringens type d toxoid | clostridium septicum - toxoid | clostridium tetani - toxoid - immunotherapy - cattle | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | heifer | h - not applicable (vet)

Nuova Zelanda - inglese - Ministry for Primary Industries

elanco new zealand - clostridium septicum toxoid; clostridium sordellii toxoid; clostridium tetani toxoid; clostridium novyi type b toxoid/cells; sodium selenate; vitamin b12; clostridium perfringens type d toxoid; clostridium chauvoei toxoid/cells - clostridium septicum toxoid 0 vaccine; clostridium sordellii toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; sodium selenate 5 g/litre; vitamin b12 0.65 g/litre; clostridium perfringens type d toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine - vaccine